Summary
Pfizer Inc. (PFE) announced a significant leadership transition through its 8-K filing on September 26, 2019, effective September 23, 2019. Executive Chairman Ian C. Read intends to retire from his roles as Executive Chairman and a Director on December 31, 2019. This move marks the end of Mr. Read's long tenure with the company, during which he held several key leadership positions, including CEO. Following Mr. Read's retirement, the Board of Directors has elected the current Chief Executive Officer, Dr. Albert Bourla, to assume the role of Chairman of the Board, effective January 1, 2020. Dr. Bourla will retain his responsibilities as CEO, consolidating leadership of the company under his direction. This strategic decision aims to ensure a seamless transition and maintain continuity in the company's strategic direction.
Key Highlights
- 1Executive Chairman Ian C. Read to retire effective December 31, 2019.
- 2Ian C. Read will step down from his position as Executive Chairman and as a Director.
- 3Dr. Albert Bourla, current CEO, elected as Chairman of the Board.
- 4Dr. Albert Bourla's appointment as Chairman is effective January 1, 2020.
- 5Dr. Albert Bourla will continue to serve as Chief Executive Officer.
- 6The filing includes a press release dated September 27, 2019, as an exhibit.